Corporate actions
Jul 16, 2018

Valeant Pharma International : Name and ISIN Change

The company Valeant Pharma International has announced and Name and ISIN change.

Accordingly, the ISIN and Name of the above mentioned contracts will change as specified in the following table.

Product code
old/new

ISIN of the underlying instrument old

ISIN of the underlying instrument new

Product-ISIN old/new

Name old

Name new

BVFF

CA91911K1021

CA0717341071

DE000A1PHMF3

Valeant Pharma International

Bausch Health Companies

The updated Contract Specifications for Futures Contracts and Options contracts at Eurex Deutschland will be published on the Eurex website www.eurexchange.com under the link:
Resources > Rules and Regulations > Contract specifications

Market Status

XEUR

The market status window is an indication regarding the current technical availability of the trading system. It indicates whether news board messages regarding current technical issues of the trading system have been published or will be published shortly.

Please find further information about incident handling in the Emergency Playbook published on the Eurex webpage under Support --> Emergencies and safeguards. Detailed information about incident communication, market re-opening procedures and best practices for order and trade reconciliation can be found in the chapters 4.2, 4.3 and 4.5, respectively. Concrete information for the respective incident will be published during the incident via newsboard message. 

We strongly recommend not to take any decisions based on the indications in the market status window but to always check the production news board for comprehensive information on an incident.

An instant update of the Market Status requires an enabled up-to date Java™ version within the browser.